Novartis acquires Regulus for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash
“Milestone Period” means the period commencing as of the Effective Time and ending at 11:59 p.m., Eastern Time, on December 31, 2034.
https://seekingalpha.com/article/4792418-regulus-therapeutics-an-undervalued-buy-with-a-0-90-cvr-and-a-7-payout
“Milestone Period” means the period commencing as of the Effective Time and ending at 11:59 p.m., Eastern Time, on December 31, 2034.
https://seekingalpha.com/article/4792418-regulus-therapeutics-an-undervalued-buy-with-a-0-90-cvr-and-a-7-payout